Nifty

:

24123.85

Sensex

:

79441.45

-18.10 (-0.08%)
-34.74 (-0.04%)

Login

Nifty
Sensex

:
:

24123.85
79441.45

-18.10 (-0.08%)
-34.74 (-0.04%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

68/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

2618.75

02-Jul-2024

Open
High
Low
Previous Close

2625.00
2698.95
2602.10
2605.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

105607
2789.93
2760.00
1377.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

44,402.17
75.26
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

43,338.95
1.22%
24.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.27
1.38
1.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.69
6.69
3.59

PAT CAGR (%)

10 Years
5 Years
3 Years

2.16
44.64
15.71

P:E (Median)

8 Years
5 Years
3 Years

60.90
53.33
42.61

P:BV (Average)

8 Years
5 Years
3 Years

14.15
15.50
16.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.25
30.02
28.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 910.87 782.16 16.46% 804.98 799.11 0.73% 953.38 905.61 5.27% 738.02 729.46 1.17%
Expenses 655.56 615.40 6.53% 587.47 571.31 2.83% 666.80 648.69 2.79% 596.77 581.53 2.62%
EBITDA 255.31 166.76 53.10% 217.51 227.80 -4.52% 286.58 256.92 11.54% 141.25 147.93 -4.52%
EBIDTM 28.03% 21.32% 27.02% 28.51% 30.06% 28.37% 19.14% 20.28%
Other Income 29.87 27.97 6.79% 28.34 23.60 20.08% 28.47 22.16 28.47% 36.80 27.79 32.42%
Interest 0.77 0.65 18.46% 0.32 0.09 255.56% 0.43 0.39 10.26% 0.28 0.68 -58.82%
Depreciation 18.10 17.18 5.36% 17.11 16.41 4.27% 18.11 16.36 10.70% 16.36 15.82 3.41%
PBT 268.71 187.30 43.47% 65.11 223.53 -70.87% 296.51 262.33 13.03% 178.71 159.22 12.24%
Tax 75.63 55.82 35.49% 19.62 59.50 -67.03% 80.97 68.77 17.74% 48.13 43.59 10.42%
PAT 193.08 131.48 46.85% 45.49 164.03 -72.27% 215.54 193.56 11.36% 130.58 115.63 12.93%
PATM 21.20% 16.81% 5.65% 20.53% 22.61% 21.37% 17.69% 15.85%
EPS 11.40 7.76 46.91% 2.69 9.68 -72.21% 12.72 11.43 11.29% 7.71 6.83 12.88%

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 929.80 787.45 18.08% 805.26 802.30 0.37% 956.99 916.87 4.38% 761.66 745.10 2.22%
Expenses 672.54 617.71 8.88% 587.20 573.60 2.37% 667.50 659.94 1.15% 617.78 596.18 3.62%
EBITDA 257.26 169.74 51.56% 218.06 228.70 -4.65% 289.49 256.93 12.67% 143.88 148.92 -3.38%
EBIDTM 27.67% 21.56% 27.08% 28.51% 30.25% 28.02% 18.89% 19.99%
Other Income 29.83 27.66 7.85% 28.11 23.42 20.03% 28.21 21.97 28.40% 36.44 27.61 31.98%
Interest 0.77 0.65 18.46% 0.32 0.09 255.56% 0.43 0.39 10.26% 0.28 0.68 -58.82%
Depreciation 18.10 17.18 5.36% 17.11 16.41 4.27% 18.11 16.36 10.70% 16.36 15.82 3.41%
PBT 270.62 189.97 42.45% 65.43 224.25 -70.82% 299.16 262.15 14.12% 180.98 160.03 13.09%
Tax 76.14 56.54 34.67% 19.71 59.69 -66.98% 81.65 68.73 18.80% 48.73 43.80 11.26%
PAT 194.48 133.43 45.75% 45.72 164.56 -72.22% 217.51 193.42 12.45% 132.25 116.23 13.78%
PATM 20.92% 16.94% 5.68% 20.51% 22.73% 21.10% 17.36% 15.60%
EPS 11.48 7.88 45.69% 2.70 9.71 -72.19% 12.84 11.42 12.43% 7.81 7.04 10.94%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales - 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 Net Sales Growth - 5.94% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% Cost Of Goods Sold - 1,288.43 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 Gross Profit - 2,118.82 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 GP Margin - 62.19% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% Total Expenditure - 2,506.60 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.87% 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.33% 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 % Of Sales - 3.33% 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% General & Admin Exp. - 190.48 189.33 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 % Of Sales - 5.59% 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.88 164.26 222.32 % Of Sales - 5.41% 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% Miscellaneous Exp. - 75.82 72.95 64.17 78.51 111.89 106.88 104.29 96.61 125.19 222.32 % Of Sales - 2.23% 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% EBITDA - 900.65 799.42 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 EBITDA Margin - 26.43% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% Other Income - 123.48 101.51 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 Interest - 1.80 1.81 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation - 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT - 952.65 833.36 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 Tax - 224.35 227.69 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 Tax Rate - 27.73% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% PAT - 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 PAT before Minority Interest - 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 17.16% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% PAT Growth - -3.31% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% EPS - 34.52 35.70 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales - 3,453.71 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 Net Sales Growth - 6.21% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% Cost Of Goods Sold - 1,334.53 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 Gross Profit - 2,119.18 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 GP Margin - 61.36% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% Total Expenditure - 2,545.02 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.86% 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.08% 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 % Of Sales - 3.29% 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% General & Admin Exp. - 190.50 189.33 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 % Of Sales - 5.52% 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.91 164.47 222.31 % Of Sales - 5.33% 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% Miscellaneous Exp. - 68.13 68.62 58.09 75.74 112.58 107.20 105.12 98.67 127.99 222.31 % Of Sales - 1.97% 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% EBITDA - 908.69 804.28 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 EBITDA Margin - 26.31% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% Other Income - 122.59 100.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 Interest - 1.80 1.81 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation - 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT - 959.80 837.37 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 Tax - 226.23 228.76 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 Tax Rate - 27.72% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% PAT - 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 PAT before Minority Interest - 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 17.08% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% PAT Growth - -2.91% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% EPS - 34.83 35.87 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,784.09 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,623.69 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 Non-Current Liabilities 106.82 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 246.21 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 Current Liabilities 1,510.94 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 Trade Payables 613.24 418.56 555.45 447.99 354.19 402.96 502.53 275.92 323.09 305.89 Other Current Liabilities 205.60 184.47 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 Total Liabilities 3,401.85 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 Gross Block 663.27 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 Accumulated Depreciation 342.91 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 196.13 Non Current Assets 636.01 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 24.49 24.49 24.49 25.82 25.97 26.17 49.43 52.99 53.63 47.67 Long Term Loans & Adv. 275.12 351.98 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 Other Non Current Assets 1.22 1.08 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 Current Assets 2,765.84 2,466.72 3,670.60 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 514.29 437.70 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,061.20 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 Other Current Assets 155.07 155.40 79.55 218.22 107.54 1,578.61 1,585.33 332.19 121.90 197.99 Short Term Loans & Adv. 24.68 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 Net Current Assets 1,254.90 1,149.69 1,996.24 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 Total Assets 3,401.85 3,194.52 4,509.70 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,777.64 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,617.24 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 Non-Current Liabilities 107.72 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 247.46 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 Current Liabilities 1,524.95 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 Trade Payables 625.41 427.79 579.33 466.13 357.06 405.81 505.86 278.93 327.74 308.04 Other Current Liabilities 207.44 184.59 503.74 450.11 222.85 802.71 842.35 390.47 202.82 130.09 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 Total Liabilities 3,410.31 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 Gross Block 680.87 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 Accumulated Depreciation 360.52 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 240.26 Non Current Assets 611.89 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 0.00 0.00 0.00 1.35 1.49 1.69 1.84 5.40 6.04 0.06 Long Term Loans & Adv. 275.44 347.40 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 Other Non Current Assets 1.24 1.10 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 Current Assets 2,798.42 2,494.26 3,707.92 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 525.05 459.97 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,063.22 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 Other Current Assets 174.87 155.48 89.49 225.89 108.85 1,580.88 1,591.97 338.90 333.82 200.47 Short Term Loans & Adv. 24.68 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 Net Current Assets 1,273.47 1,167.89 2,009.49 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 Total Assets 3,410.31 3,193.03 4,520.02 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 578.94 487.94 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 PBT 952.65 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 Adjustment -46.14 -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 Changes in Working Capital 64.55 -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 Cash after chg. in Working capital 971.06 757.61 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.67 -262.86 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 14.97 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 333.11 989.73 -47.11 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 Cash from Financing Activity -561.50 -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 32.41 -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 Opening Cash & Equivalents 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 Closing Cash & Equivalent 62.15 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 582.02 484.23 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 PBT 959.80 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 Adjustment -45.13 -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 Changes in Working Capital 61.02 -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 Cash after chg. in Working capital 975.69 755.75 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -254.23 -264.71 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 8.71 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 326.85 992.39 -32.96 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 Cash from Financing Activity -561.50 -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 29.23 -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 Opening Cash & Equivalents 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 Closing Cash & Equivalent 64.17 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.85 103.58 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 ROA 17.73% 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% ROE 32.96% 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% ROCE 45.85% 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% Fixed Asset Turnover 5.76 5.77 5.93 3.04 3.21 6.48 8.22 11.35 10.32 11.16 Receivable days 20.23 20.54 21.73 18.45 12.47 15.60 20.03 18.12 14.65 10.40 Inventory Days 46.48 49.10 53.51 58.87 54.87 57.56 58.34 57.72 57.50 37.61 Payable days 146.15 142.20 141.33 117.18 57.46 72.90 65.55 50.91 53.40 43.13 Cash Conversion Cycle -79.44 -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 450.79 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.47 102.89 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 ROA 17.87% 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% ROE 33.43% 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% ROCE 46.49% 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% Fixed Asset Turnover 5.25 5.31 6.03 3.04 3.21 6.48 8.21 11.38 9.59 9.82 Receivable days 21.90 22.32 21.37 18.42 12.47 15.60 20.03 18.09 14.59 10.35 Inventory Days 52.05 55.82 54.91 60.14 54.88 57.56 58.36 57.89 57.97 38.01 Payable days 144.03 143.05 140.69 119.53 57.89 73.24 66.07 51.56 53.81 43.72 Cash Conversion Cycle -70.08 -64.91 -64.41 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 454.77 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26

Top Investors:

lici asm non par

aditya birla sun life trustee private limited a/c

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
17th May 2024, 13:58 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback